Literature DB >> 21487045

The two faces of capsaicin.

Ann M Bode1, Zigang Dong.   

Abstract

Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is the principal pungent component in hot peppers, including red chili peppers, jalapeños, and habaneros. Consumed worldwide, capsaicin has a long and convoluted history of controversy about whether its consumption or topical application is entirely safe. Conflicting epidemiologic data and basic research study results suggest that capsaicin can act as a carcinogen or as a cancer preventive agent. Capsaicin is unique among naturally occurring irritant compounds because the initial neuronal excitation evoked is followed by a long-lasting refractory period, during which the previously excited neurons are no longer responsive to a broad range of stimuli. This process is referred to as desensitization and has been exploited for its therapeutic potential. Capsaicin-containing creams have been in clinical use for many years to relieve a variety of painful conditions. However, their effectiveness in pain relief is also highly debated and some adverse side effects have been reported. We have found that chronic, long-term topical application of capsaicin increased skin carcinogenesis in mice treated with a tumor promoter. These results might imply that caution should be exercised when using capsaicin-containing topical applications in the presence of a tumor promoter, such as, for example, sunlight. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21487045     DOI: 10.1158/0008-5472.CAN-10-3756

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  Capsaicin inhibits cell proliferation by cytochrome c release in gastric cancer cells.

Authors:  Ogunc Meral; Merve Alpay; Gorkem Kismali; Funda Kosova; Dilek Ulker Cakir; Mert Pekcan; Serbulent Yigit; Tevhide Sel
Journal:  Tumour Biol       Date:  2014-03-30

2.  A review of the high-concentration capsaicin patch and experience in its use in the management of neuropathic pain.

Authors:  Ganesan Baranidharan; Sangeeta Das; Arun Bhaskar
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

Review 3.  Toxic phytochemicals and their potential risks for human cancer.

Authors:  Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-27

Review 4.  Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials.

Authors:  Girish B Maru; Rasika R Hudlikar; Gaurav Kumar; Khushboo Gandhi; Manoj B Mahimkar
Journal:  World J Biol Chem       Date:  2016-02-26

5.  Oxidant-based anticancer activity of a novel synthetic analogue of capsaicin, capsaicin epoxide.

Authors:  Anna Lewinska; Pawel Chochrek; Karolina Smolag; Ewa Rawska; Maciej Wnuk
Journal:  Redox Rep       Date:  2014-11-08       Impact factor: 4.412

6.  Fungal Seed Pathogens of Wild Chili Peppers Possess Multiple Mechanisms To Tolerate Capsaicinoids.

Authors:  Catharine A Adams; Kolea Zimmerman; Kristi Fenstermacher; Mitchell G Thompson; Will Skyrud; Scott Behie; Anne Pringle
Journal:  Appl Environ Microbiol       Date:  2020-01-21       Impact factor: 4.792

Review 7.  Next-Gen Therapeutics for Skin Cancer: Nutraceuticals.

Authors:  Annapoorna Sreedhar; Jun Li; Yunfeng Zhao
Journal:  Nutr Cancer       Date:  2018-05-15       Impact factor: 2.900

Review 8.  A Mechanism-Based Approach to the Management of Osteoarthritis Pain.

Authors:  Ezra Cohen; Yvonne C Lee
Journal:  Curr Osteoporos Rep       Date:  2015-12       Impact factor: 5.096

Review 9.  New insights into pharmacological tools to TR(i)P cancer up.

Authors:  M Gautier; I Dhennin-Duthille; A S Ay; P Rybarczyk; I Korichneva; H Ouadid-Ahidouch
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 10.  Anticancer Activity of Natural and Synthetic Capsaicin Analogs.

Authors:  Jamie R Friedman; Nicholas A Nolan; Kathleen C Brown; Sarah L Miles; Austin T Akers; Kate W Colclough; Jessica M Seidler; John M Rimoldi; Monica A Valentovic; Piyali Dasgupta
Journal:  J Pharmacol Exp Ther       Date:  2017-12-15       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.